<DOC>
	<DOC>NCT02288260</DOC>
	<brief_summary>This NIS is a multi-centre, observational, descriptive, cross-sectional study including all consecutive patients with Acute Coronary Syndrome (ACS) and a single-arm, prospective, longitudinal cohort study which will include patients hospitalized for ACS and who are with ticagrelor on discharge from hospital.</brief_summary>
	<brief_title>RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Part A,B: Subjects whose data have been entered in the Russian ACS Registry PART A,B: Discharged from hospital after MI with STsegment elevation (STEMI), MI NST segment elevation (NSTEMI) or Unstable angina. Hospitalized during 24 hours of ACS symptoms onset Part B: Patients on ticagrelor at the time of discharge from hospital The existence of serious / severe concomitant diseases which can in the short term (i.e. within 6 months) limit the duration of life Current participation in a clinical trial with a nonlicensed investigational medicinal product</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Russian ACS Registry</keyword>
	<keyword>ticagrelor</keyword>
</DOC>